Detalhe da pesquisa
1.
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Brain
; 144(12): 3742-3755, 2021 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145880
2.
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.
Alzheimers Dement
; 11(9): 1050-68, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25457431
3.
Digital health and inpatient palliative care: a cohort-controlled study.
BMJ Support Palliat Care
; 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491147
4.
GP assessment of unmet need in a complex multimorbid population using a data-driven and clinical triage system: a prospective cohort study.
BJGP Open
; 7(4)2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385665
5.
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.
J Nucl Med
; 64(2): 294-303, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137760
6.
In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology.
Res Sq
; 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909660
7.
Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET.
Alzheimers Dement (N Y)
; 9(1): e12372, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36873926
8.
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
Alzheimers Dement (N Y)
; 8(1): e12325, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846158
9.
Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.
Alzheimers Dement (N Y)
; 8(1): e12258, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35310526
10.
Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Alzheimers Res Ther
; 14(1): 40, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260178
11.
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Alzheimers Dement (N Y)
; 7(1): e12106, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614888
12.
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.
Sci Rep
; 11(1): 10867, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108509
13.
Value-Generating Exploratory Trials in Neurodegenerative Dementias.
Neurology
; 96(20): 944-954, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674360
14.
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
Alzheimers Dement (N Y)
; 6(1): e12107, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33344752
15.
Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
Neurology
; 95(2): e166-e178, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580974
16.
Statistical Considerations for Planning Clinical Trials with Quantitative Imaging Biomarkers.
J Natl Cancer Inst
; 111(1): 19-26, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597055
17.
Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
J Alzheimers Dis
; 70(1): 131-138, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31156181
18.
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.
J Parkinsons Dis
; 9(3): 553-563, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306141
19.
Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
BMJ Open
; 8(11): e023664, 2018 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478117
20.
Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.
BMJ Open
; 8(3): e019362, 2018 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574441